Celldex Therapeutics Inc CLDX Ratios d'évaluation et statistiques sur les actions

Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
Celldex Therapeutics Inc (CLDX)
Celldex Therapeutics Inc (CLDX) Bilan Comptable

Celldex Therapeutics Inc (CLDX)

24,24

-0,37

(-1,50%)

Fermé 23 Janvier 10:00PM

Retardé de 15 minutes

24,24

0,00

( 0,00% )

Avant marché: 10:00AM

Retardé de 15 minutes

Statistiques

Annuel Trimestriel

Fin d'année 31 Décembre 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-35.656	-26.619	-64.138	-36.505	-33.325	-20.724	-28.173	-34.564
Return on Equity (%)	-46.272	-37.079	-83.891	-46.659	-39.409	-22.426	-30.127	-37.446
Return on Invested Capital (%)	-49.488	-38.364	-25.673	-49.262	-29.107	-20.498	-29.934	-40.913
Operating Margin (%)	-1894.047	-920.607	-1593.091	-1423.957	-821.61	-1520.92	-4765.592	-2054.758
Net Profit Margin (%)	-1894.047	-730.056	-1585.07	-1423.957	-805.878	-1516.04	-4765.592	-2054.758
Book Value Per Share	0.771	0.562	6.303	2.671	4.511	8.395	6.335	8.505
Earnings Per Share	-1.066	-0.672	-12.643	-2.998	-1.509	-1.509	-2.38	-2.992
Cash Per Share	0.352	0.291	2.033	0.662	1.107	0.838	0.623	0.737
Working Capital Per Share	1.33	0.845	7.232	3.244	4.637	8.438	6.336	8.475
Operating Profit Per Share	0.056	0.098	3.275	0.287	0.294	0.13	0.195	0.146
EBIT Per Share	-1.066	-0.847	-12.707	-2.998	-1.539	-1.514	-2.38	-2.992
EBITDA Per Share	-1.066	-0.847	-12.707	-2.998	-1.539	-1.514	-2.38	-2.992
Free Cash Flow Per Share	-1.078	-0.697	-12.893	-3.114	-1.521	-1.548	-2.402	-3.017

Liquidity Ratios

Fin d'année 31 Décembre 2023	2016	2017	2018	2019	2020	2021	2022	2023
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Actions en circulation	120,52M	138,52M	11,96M	16,97M	39,6M	46,73M	47,2M	N/A

Statistiques et ratios clés

Fin d'année 31 Décembre 2023	Déc 2022	Mar 2023	Juin 2023	Sept 2023	Déc 2023	Mar 2024	Juin 2024	Sept 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Actions en circulation	47,2M	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	-3036.298	N/A	N/A	N/A	-21030.769	N/A	N/A
Net Profit Margin (%)	N/A	-3036.298	N/A	N/A	N/A	-21030.769	N/A	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Statistiques et ratios clés

Capitalisation boursière	1,61B
Ratio cours/bénéfice	-11,37
Ratio prix/ventes	233,75
Ratio prix/liquidités	46,2
Ratio prix/valeur comptable	3,75
Rendement de dividende	-

Statistiques sur les actions

Actions en circulation	66,34M
Volume moyen (1 semaine)	839,24k
Volume moyen (1 mois)	1,05M
Variation sur 52 semaines	-39,76%
Plus haut sur 52 semaines	53,18
Plus bas sur 52 semaines	22,165

Plus de ratios bientôt disponibles !

Celldex Therapeutics

SG Issuer Societe Generale

Societe Generale Effekten

Societe Generale

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales